These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21616187)

  • 21. Gene silencing in vitro and in vivo using intronic microRNAs.
    Deng JH; Deng P; Lin SL; Ying SY
    Methods Mol Biol; 2015; 1218():321-40. PubMed ID: 25319661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viral vector-mediated RNA interference.
    Couto LB; High KA
    Curr Opin Pharmacol; 2010 Oct; 10(5):534-42. PubMed ID: 20620113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron.
    Liu YP; Haasnoot J; ter Brake O; Berkhout B; Konstantinova P
    Nucleic Acids Res; 2008 May; 36(9):2811-24. PubMed ID: 18346971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction and in vitro antiviral activity of highly effective artificial miRNA targeting to HIV-1 pol].
    Cheng T; Zhang T; Zhang Y; Wei L; Xia D; Wang Y; Zhang J; Xia N
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):63-73. PubMed ID: 20353094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles.
    Ely A; Naidoo T; Arbuthnot P
    Nucleic Acids Res; 2009 Jul; 37(13):e91. PubMed ID: 19474340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA interference and antiviral therapy.
    Ma Y; Chan CY; He ML
    World J Gastroenterol; 2007 Oct; 13(39):5169-79. PubMed ID: 17876887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pSM155 and pSM30 vectors for miRNA and shRNA expression.
    Wu J; Bonsra AN; Du G
    Methods Mol Biol; 2009; 487():205-19. PubMed ID: 19301649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene silencing in vitro and in vivo using intronic microRNAs.
    Lin SL; Ying SY
    Methods Mol Biol; 2006; 342():295-312. PubMed ID: 16957384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies in designing multigene expression units to downregulate HIV-1.
    Zhang J; Rossi JJ
    Methods Mol Biol; 2010; 623():123-36. PubMed ID: 20217548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection.
    Pfeffer S; Baumert TF
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):431-5. PubMed ID: 20537478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of a microRNA expression vector for function analysis of microRNA.
    Furukawa N; Sakurai F; Katayama K; Seki N; Kawabata K; Mizuguchi H
    J Control Release; 2011 Feb; 150(1):94-101. PubMed ID: 21146569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
    Thibault PA; Wilson JA
    Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene silencing in vitro and in vivo using intronic microRNAs.
    Lin SL; Ying SY
    Methods Mol Biol; 2013; 936():209-29. PubMed ID: 23007511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycistronic expression of interfering RNAs from RNA polymerase III promoters.
    Steel LF; Sanghvi VR
    Methods Mol Biol; 2012; 815():347-59. PubMed ID: 22131004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.
    Boden D; Pusch O; Silbermann R; Lee F; Tucker L; Ramratnam B
    Nucleic Acids Res; 2004; 32(3):1154-8. PubMed ID: 14966264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy.
    Liu YP; Westerink JT; ter Brake O; Berkhout B
    Methods Mol Biol; 2011; 721():293-311. PubMed ID: 21431693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of HBV replication by antiviral microRNAs transferred by lentiviral vectors for potential cell and gene therapy approaches.
    Kumar M; Follenzi A; Garforth S; Gupta S
    Antivir Ther; 2012; 17(3):519-28. PubMed ID: 22300804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
    Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
    Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delivery of RNA interference triggers to sensory neurons in vivo using herpes simplex virus.
    Anesti AM; Coffin RS
    Expert Opin Biol Ther; 2010 Jan; 10(1):89-103. PubMed ID: 20420517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Construction of highly effective artifical miRNA targeted to HIV-1 vif and the lentiviral-mediated antiviral research in vitro].
    Zhang T; Cheng T; Wei LH; Zhang YL; Wang YB; Cai YJ; Zhang J; Xia NS
    Bing Du Xue Bao; 2010 Jan; 26(1):8-15. PubMed ID: 20329552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.